Nutrien’s 17% Rally Reflects Potash Momentum, But Execution Risks Linger

What happened

Nutrien's shares have risen 17% over the past six months, buoyed by strong fertilizer demand, rising potash prices, and cost-cutting measures. The gains align with the company's record potash volumes in 2025 and a tight global supply-demand balance that supports 2026 guidance of 14.1–14.8 million tonnes. However, the rally has pushed the stock to $71.78, near the upper end of our base case valuation, leaving limited upside unless potash prices exceed expectations or the phosphate strategic review delivers a value-accretive outcome. The DeepValue analysis highlights a ±$280 million Adjusted EBITDA sensitivity per $25/tonne potash price move, meaning small price changes can significantly impact earnings. While the near-term backdrop is favorable, risks remain from Brazil farm affordability, phosphate margin pressure, and the need for concrete portfolio simplification actions by year-end.

Implication

The stock's 17% gain embeds expectations of strong potash demand, but investors should monitor quarterly volume deliveries and any phosphate strategic alternative announcements. At $71.78, the risk/reward is balanced; the base case implies $80, offering limited upside, while the bear case of $62 suggests downside if potash prices soften. We recommend maintaining positions but not adding aggressively until the phosphate catalyst becomes clearer.

Thesis delta

The recent news reinforces the potash-driven narrative, but the stock has already moved closer to our base case, reducing the margin of safety. The key catalyst remains the phosphate strategic alternatives outcome in 2026; without it, the thesis is more reliant on potash pricing. We see a modest shift toward caution as the stock price rises, with upside now more dependent on execution rather than valuation expansion.